Annette Busmann

630 total citations
9 papers, 313 citations indexed

About

Annette Busmann is a scholar working on Molecular Biology, Pharmaceutical Science and Oncology. According to data from OpenAlex, Annette Busmann has authored 9 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Pharmaceutical Science and 2 papers in Oncology. Recurrent topics in Annette Busmann's work include Chemical Synthesis and Analysis (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Receptor Mechanisms and Signaling (2 papers). Annette Busmann is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Receptor Mechanisms and Signaling (2 papers). Annette Busmann collaborates with scholars based in Germany, Greece and Thailand. Annette Busmann's co-authors include Martin Wendland, Wolf‐Georg Forssmann, Markus Meyer, Harald John, Rudolf Richter, Nikolaj Spodsberg, Erik Maronde, Fred A. Rainey, Knut Adermann and H. Diekmann and has published in prestigious journals such as FEBS Letters, Science Translational Medicine and British Journal of Pharmacology.

In The Last Decade

Annette Busmann

9 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Busmann Germany 7 114 102 66 51 38 9 313
Jenny M. McLaughlan United Kingdom 5 171 1.5× 120 1.2× 77 1.2× 39 0.8× 17 0.4× 6 341
Leah J. Anderson United States 8 147 1.3× 84 0.8× 54 0.8× 37 0.7× 24 0.6× 12 320
Qiujiang Du Canada 10 134 1.2× 75 0.7× 71 1.1× 19 0.4× 22 0.6× 11 308
Octavio A. Quiñones United States 13 216 1.9× 60 0.6× 110 1.7× 69 1.4× 92 2.4× 17 498
Oonagh T. Lynch United Kingdom 8 129 1.1× 109 1.1× 160 2.4× 76 1.5× 6 0.2× 10 402
Raymond G. Fox United States 12 218 1.9× 125 1.2× 30 0.5× 37 0.7× 53 1.4× 24 480
Sheikh Mohammad Fazle Akbar Japan 12 165 1.4× 215 2.1× 88 1.3× 35 0.7× 14 0.4× 27 462
Gregory M. Frechette United States 7 152 1.3× 29 0.3× 88 1.3× 23 0.5× 12 0.3× 11 331
Betül Demir Türkiye 11 63 0.6× 102 1.0× 39 0.6× 30 0.6× 14 0.4× 49 333
Ghania Ramdani France 10 165 1.4× 56 0.5× 72 1.1× 68 1.3× 6 0.2× 13 382

Countries citing papers authored by Annette Busmann

Since Specialization
Citations

This map shows the geographic impact of Annette Busmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Busmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Busmann more than expected).

Fields of papers citing papers by Annette Busmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Busmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Busmann. The network helps show where Annette Busmann may publish in the future.

Co-authorship network of co-authors of Annette Busmann

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Busmann. A scholar is included among the top collaborators of Annette Busmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Busmann. Annette Busmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Forssmann, Wolf‐Georg, Matthias Stoll, Knut Adermann, et al.. (2010). Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide. Science Translational Medicine. 2(63). 63re3–63re3. 58 indexed citations
2.
Busmann, Annette, Harald Tammen, Christoph Menzel, et al.. (2007). Peptidomic analysis of human peripheral monocytes persistently infected by Chlamydia trachomatis. Medical Microbiology and Immunology. 196(2). 103–114. 2 indexed citations
3.
Busmann, Annette, et al.. (2005). Discovery of Novel Regulatory Peptides by Reverse Pharmacology: Spotlight on Chemerin and the RF-amide Peptides Metastin and QRFP. Current Protein and Peptide Science. 6(3). 265–278. 18 indexed citations
4.
Busmann, Annette, et al.. (2004). A three-step purification strategy for isolation of hamster TIG2 from CHO cells: characterization of two processed endogenous forms. Journal of Chromatography B. 811(2). 217–223. 7 indexed citations
5.
Schulz, Axel, et al.. (2004). Stability and Cleavage Conditions of (2-Furyl)-L-Alanine-Containing Peptides. Protein and Peptide Letters. 11(6). 601–606. 5 indexed citations
6.
Busmann, Annette, et al.. (2004). A three-step purification strategy for isolation of hamster TIG2 from CHO cells: characterization of two processed endogenous forms. Journal of Chromatography B. 811(2). 217–223. 7 indexed citations
7.
Busmann, Annette, Martin Wendland, C Berger, et al.. (2003). Identification and functional characterization of hemorphins VV‐H‐7 and LVV‐H‐7 as low‐affinity agonists for the orphan bombesin receptor subtype 3. British Journal of Pharmacology. 138(8). 1431–1440. 31 indexed citations
8.
Wendland, Martin, Annette Busmann, Nikolaj Spodsberg, et al.. (2003). Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Letters. 555(3). 495–499. 170 indexed citations
9.
Busmann, Annette, et al.. (1996). A Syntrophic Propionate-Oxidizing, Sulfate-Reducing Bacterium from a Fluidized Bed Reactor. Systematic and Applied Microbiology. 19(3). 414–420. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026